How to Build a Live Compliance Tracker for Your Telehealth Brand

A live compliance tracker for telehealth advertising is not a spreadsheet you update once a quarter and then forget. It is a working system that your marketing, legal, and clinical teams interact with regularly — one that gives every person touching your advertising a real-time picture of what claims are approved, what evidence supports them, what platform restrictions apply, and what regulatory changes have occurred since the last review. Building this kind of system takes initial effort, but it pays for itself the first time it catches a problem before a regulator or platform does.

Most telehealth brands operate without a formal compliance tracker. Their compliance knowledge lives in the heads of a few people — the founder, the legal advisor, the media buyer who has learned from painful experience. When those people are not in the room, non-compliant claims make it into ads. When they leave the company, that institutional knowledge walks out with them. A live compliance tracker transfers that knowledge into a system that survives turnover and scales with the business.

The Four Components of a Useful Compliance Tracker

A practical live compliance tracker for a telehealth brand has four components. First, a claims registry: a documented list of every claim currently made in the brand's advertising, with the substantiation supporting each claim, the platform restrictions that apply to each claim, and the last date the claim and its substantiation were reviewed. Second, a regulatory monitoring log: a running record of FDA warning letters, FTC enforcement actions, and platform policy changes relevant to your category, with notes on how each development affects your current claim set.

Third, an ad asset inventory: a record of all active creative assets — which ads are running, where, with what claims — so that when a policy change requires updating claims, you can identify every affected asset immediately rather than discovering them ad hoc. Fourth, a review queue: a structured process for reviewing new creative before it goes live, with documented sign-off from whoever is responsible for compliance in your organization. These four components together give you a system that tracks compliance state rather than just compliance intent.

Building the Claims Registry

The claims registry is the most important component and the most effort to build initially. Start by auditing every active ad in your ad accounts — pull all current ad copy and identify every unique claim being made. A claim is any statement about your product or service that a consumer could rely on in making a decision — efficacy claims, safety claims, comparison claims, pricing claims, testimonial-based claims. Group identical or substantially similar claims, and for each unique claim, document the specific wording used in advertising.

For each claim in the registry, document: the substantiation (specific studies, prescribing information, or internal data that supports the claim); the platform restrictions (which platforms allow this claim without modification, which require specific disclaimer language, which prohibit it); the regulatory basis (FDA, FTC, or state rule that governs this claim type); and the review date. The review date forces a recertification cadence — claims that have not been reviewed in the last 90 days are flagged for re-review, because the regulatory and platform environment may have changed. See our guide to substantiating health claims in telehealth ads for the evidence standard that each registry entry needs to meet.

Regulatory Monitoring That Feeds the Tracker

A compliance tracker that is not connected to regulatory monitoring goes stale quickly. The FDA warning letters, FTC consent orders, and platform policy updates that affect telehealth advertising are publicly available — but they require a monitoring system to catch them in time to respond proactively rather than reactively. A practical monitoring system for a telehealth brand at moderate scale involves: weekly review of FDA's warning letter database for health-related letters, monthly review of FTC enforcement actions in the health and wellness category, and subscription to platform policy update notifications from Meta, Google, and TikTok.

When a monitoring event is identified — a warning letter targeting a claim pattern similar to yours, an FTC consent order that sets a new standard, a platform policy update — the compliance tracker should be updated to note the development and its implications for your current claim set. If an existing claim in your registry is affected by the regulatory development, the claim should be flagged for immediate review rather than waiting for its scheduled review date. This real-time update process is what makes the tracker "live" rather than just a static document.

The Ad Asset Inventory

Knowing what claims your brand makes in theory is not sufficient — you also need to know where those claims are currently running in practice. The ad asset inventory connects the claims registry to the live advertising environment. For each active campaign and ad set, the inventory records the creative assets running, the claims present in each asset, the platforms where each asset is active, and the date the asset last went through compliance review.

This inventory is most valuable when you need to make a rapid change — for example, when a platform policy update prohibits a claim that is currently in multiple running ads. Without an asset inventory, identifying all the ads containing that claim requires manually reviewing every creative in your ad accounts. With an asset inventory, you can identify the affected assets immediately, pause them, and replace them with reviewed alternatives. The time difference between these two approaches — when a platform is actively reviewing your account for a policy violation — can determine whether you face an account flag or successfully correct the violation before it triggers enforcement. See our telehealth ad compliance checklist for the pre-launch review framework that feeds the asset inventory.

The Review Queue and Sign-Off Process

Every piece of new creative — every ad, every landing page, every email that makes claims about your telehealth service — should go through a documented review before it goes live. The review queue is the mechanism that enforces this requirement. New creative enters the queue when it is submitted for review, the relevant reviewer (legal, medical director, compliance officer, or a designated senior marketer with compliance training) reviews it against the claims registry and the applicable platform policies, and the review outcome — approved, approved with modifications, or rejected — is documented with the reviewer's name and date.

The sign-off documentation is what transforms the review queue from an informal process into a defensible compliance system. If the FTC or FDA asks how you ensure that your advertising claims are substantiated and compliant, you can point to documented review records showing that every ad was reviewed and approved before publication, with the specific compliance basis recorded. This documentation does not guarantee immunity from enforcement, but it demonstrates good faith compliance processes that regulators treat more favorably than brands that have no compliance records at all. See our guide to how telehealth ad compliance review works for the process design.

Tools for Running the Tracker

The tracker does not require specialized software. Most telehealth brands at early and mid-scale run effective compliance trackers in Notion, Airtable, or Google Sheets. The claims registry works well in a spreadsheet with filtering and tagging by category, platform, and review status. The ad asset inventory can live in the same workspace with links to creative assets stored in your ad platform or creative library. The review queue can be implemented as a simple project management workflow — new assets submitted as tasks, assigned to the reviewer, closed when review is complete with documented outcome.

The key is not the tool — it is the consistent use of the tool. A compliance tracker that is updated every time a new claim is introduced, every time an existing claim is reviewed, and every time a regulatory monitoring event occurs is effective regardless of the software it runs on. A sophisticated compliance software system that is not consistently updated is less effective than a simple spreadsheet that is. Building the update habits — making tracker maintenance a standard part of the ad production and review workflow rather than a separate compliance task — is what makes the difference between a compliance tracker that works and one that sits unused.